| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |